Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Labeling of cell therapies: How can we get it right?

Item Type:Article
Title:Labeling of cell therapies: How can we get it right?
Creators Name:Waiczies, S. and Niendorf, T. and Lombardi, G.
Abstract:Labeling cells for non-invasive tracking in vivo using magnetic resonance imaging (MRI) is an emerging hot topic garnering ever increasing attention, yet it is fraught with numerous methodological challenges, which merit careful attention. Several of the current procedures used to label cells for tracking by MRI take advantage of the intrinsic phagocytic nature of cells to engulf nanoparticles, though cells with low intrinsic phagocytic capacity are also commonly studied. Before we take the next steps towards administering such cells in vivo, it is essential to understand how the nanolabel is recognized, internalized, trafficked and distributed within the specific host cell. This is even more critical when contemplating labeling of cells that may ultimately be applied in vivo to patients in a therapeutic context.
Keywords:Cell Labeling, Cell Tracking, Clinical Application, Electron Microscopy, Excess Nanoparticles, Internalization, Intracellular, Membrane-Bound, MRI, NK Cells, Phagocytes, Nanolabel, Nanoparticles, Patient Studies, T Cells
Source:OncoImmunology
ISSN:2162-402X
Publisher:Taylor & Francis (U.S.A.)
Volume:6
Number:10
Page Range:e1345403
Date:20 July 2017
Official Publication:https://doi.org/10.1080/2162402X.2017.1345403
External Fulltext:View full text on PubMed Central
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library